Theriva Biologics, Inc. (TOVX) Free cash flow 2016–2025
Theriva Biologics, Inc. (TOVX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.7MFY2025 · since FY2016: -$28.5M → -$16.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.7M | +1.4% |
| FY2024 | -$16.9M | +11.8% |
| FY2023 | -$19.2M | +0.0% |
| FY2022 | -$19.2M | -48.8% |
| FY2021 | -$12.9M | -6.0% |
| FY2020 | -$12.2M | +12.2% |
| FY2019 | -$13.9M | +19.7% |
| FY2018 | -$17.3M | +15.3% |
| FY2017 | -$20.4M | +28.3% |
| FY2016 | -$28.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice